VBI Vaccines (VBIV) Stock Chart & Stock Price History → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free VBIV Stock Alerts $0.60 0.00 (-0.25%) (As of 10:24 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability VBI Vaccines Stock Price Performance5 Day Performance+1.69%1 Month Performance-9.09%3 Month Performance-11.75%6 Month Performance-0.02%Year-To-Date Performance+2.13%1 Year Performance-81.42% Receive VBIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. VBIV Stock Chart for Thursday, May, 9, 2024 VBIV Chart by TradingView VBI Vaccines Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.60$0.60-0.33%$0.62$0.5938,563 shs$17.21 million05/07/2024$0.60$0.60+0.35%$0.63$0.58109,052 shs$17.27 million05/06/2024$0.59$0.60+1.68%$0.60$0.56138,068 shs$17.21 million05/03/2024$0.58$0.59+1.27%$0.61$0.57165,340 shs$16.92 million05/02/2024$0.57$0.58+2.30%$0.59$0.5682,412 shs$16.71 million05/01/2024$0.57$0.57-0.26%$0.58$0.5671,760 shs$16.19 million Get the Latest News and Ratings for VBIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.56$0.57+1.24%$0.57$0.54115,430 shs$16.23 million04/29/2024$0.57$0.56-1.74%$0.59$0.53483,754 shs$16.04 million04/26/2024$0.60$0.57-4.24%$0.60$0.56187,246 shs$16.32 million04/25/2024$0.59$0.60+1.59%$0.60$0.56123,634 shs$17.04 million04/24/2024$0.61$0.59-3.04%$0.61$0.58130,137 shs$16.78 million04/23/2024$0.60$0.61+0.91%$0.62$0.58112,934 shs$17.30 million04/22/2024$0.63$0.60-4.84%$0.66$0.58302,393 shs$17.14 million04/19/2024$0.63$0.63+0.64%$0.65$0.61163,515 shs$18.02 million04/18/2024$0.61$0.63+3.40%$0.64$0.58179,877 shs$14.92 million04/17/2024$0.62$0.61-1.77%$0.65$0.58373,465 shs$14.43 million04/16/2024$0.58$0.62+6.90%$0.64$0.56469,600 shs$14.69 million04/15/2024$0.58$0.58$0.58$0.55273,042 shs$13.74 million04/12/2024$0.60$0.58-3.33%$0.61$0.55505,812 shs$13.74 million04/11/2024$0.64$0.60-5.96%$0.63$0.55611,297 shs$14.21 million04/10/2024$0.66$0.64-3.33%$0.73$0.571.69 million shs$15.11 million04/09/2024$0.92$0.66-28.34%$1.35$0.656.74 million shs$15.64 million04/08/2024$0.71$0.92+29.72%$0.98$0.701.43 million shs$21.82 million04/05/2024$0.67$0.71+6.26%$0.72$0.65235,992 shs$16.82 million04/04/2024$0.75$0.67-11.18%$0.77$0.661.87 million shs$15.83 million04/03/2024$0.70$0.75+7.47%$0.77$0.662.67 million shs$17.82 million04/02/2024$0.62$0.70+13.25%$0.73$0.593.86 million shs$16.58 million04/01/2024$0.60$0.62+2.57%$0.63$0.60171,407 shs$14.64 million03/29/2024$0.60$0.60$0.61$0.59128,704 shs$14.28 million03/28/2024$0.58$0.60+3.90%$0.61$0.59125,291 shs$14.28 million03/27/2024$0.58$0.58$0.59$0.5690,814 shs$13.74 million03/26/2024$0.57$0.58+0.89%$0.59$0.5836,652 shs$13.74 million03/25/2024$0.58$0.57-0.05%$0.59$0.5634,132 shs$13.62 million03/22/2024$0.57$0.58+1.81%$0.59$0.5648,163 shs$13.63 million03/21/2024$0.58$0.57-1.74%$0.60$0.5690,415 shs$13.39 million03/20/2024$0.56$0.58+2.29%$0.60$0.5872,746 shs$13.62 million03/19/2024$0.57$0.56-1.40%$0.59$0.5628,154 shs$13.32 million03/18/2024$0.56$0.57+1.68%$0.59$0.5751,553 shs$13.51 million03/15/2024$0.59$0.56-4.92%$0.60$0.5644,631 shs$13.28 million03/14/2024$0.59$0.59-0.05%$0.61$0.5781,668 shs$13.97 millionThings Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution.03/13/2024$0.60$0.59-0.91%$0.63$0.5945,503 shs$13.98 million03/12/2024$0.60$0.60-0.77%$0.63$0.5985,255 shs$14.11 million03/11/2024$0.58$0.60+3.45%$0.64$0.58170,956 shs$14.21 million03/08/2024$0.58$0.58-0.84%$0.59$0.56111,948 shs$13.74 million03/07/2024$0.60$0.58-1.70%$0.60$0.5736,669 shs$13.86 million03/06/2024$0.58$0.60+2.23%$0.60$0.5842,500 shs$14.09 million03/05/2024$0.60$0.58-2.43%$0.60$0.57131,582 shs$13.79 million03/04/2024$0.59$0.60+1.10%$0.60$0.57108,678 shs$14.13 million03/01/2024$0.58$0.59+1.72%$0.60$0.5775,887 shs$13.98 million02/29/2024$0.57$0.58+2.64%$0.59$0.5692,190 shs$13.74 million02/28/2024$0.57$0.57+0.02%$0.59$0.5662,521 shs$13.39 million02/27/2024$0.58$0.57-3.10%$0.59$0.5668,248 shs$13.39 million02/26/2024$0.57$0.58+2.28%$0.60$0.5649,149 shs$13.81 million02/23/2024$0.57$0.57+0.90%$0.60$0.5721,063 shs$13.51 million02/22/2024$0.63$0.57-10.46%$0.65$0.55198,171 shs$13.39 million02/21/2024$0.63$0.63+0.14%$0.65$0.60179,712 shs$14.95 million02/20/2024$0.65$0.63-2.49%$0.65$0.60166,586 shs$14.93 million02/19/2024$0.65$0.65$0.70$0.60397,500 shs$15.31 million02/16/2024$0.60$0.65+7.68%$0.70$0.60396,795 shs$15.31 million02/15/2024$0.58$0.60+4.18%$0.68$0.561.34 million shs$14.22 million02/14/2024$0.66$0.58-12.73%$0.73$0.531.00 million shs$13.65 million02/13/2024$0.69$0.66-4.49%$0.70$0.6577,562 shs$15.64 million02/12/2024$0.68$0.69+1.63%$0.70$0.6757,394 shs$16.37 million02/09/2024$0.65$0.68+4.52%$0.69$0.6640,840 shs$16.11 million02/08/2024$0.64$0.65+1.80%$0.69$0.6331,899 shs$15.41 million Related Companies: Minerva Neurosciences Stock Chart Aytu BioPharma Stock Chart Vincerx Pharma Stock Chart Indaptus Therapeutics Stock Chart NeuroSense Therapeutics Stock Chart Talphera Stock Chart Traws Pharma Stock Chart Vaxxinity Stock Chart Tonix Pharmaceuticals Stock Chart Orgenesis Stock Chart Receive VBIV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VBIV) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.